News & Updates

A Singapore study based on a single surgeon’s experience has demonstrated the safe adoption of laparoscopic liver resection (LLR) for resections of all difficulty grades, including major resections and resection of tumours located in the difficult posterosuperior segments with a low open conversion rate.

Bariatric surgery significantly lowers the risk of major adverse liver outcomes and major adverse cardiovascular events (MACE) – the dual primary endpoints – in obese patients with biopsy-driven nonalcoholic steatohepatitis (NASH) in the SPLENDOR* study.

Cyproheptadine appears to induce hunger in adults with poor appetite, as shown in a study.

Transitioning patients on extracorporeal life support (ECLS) to cardiopulmonary bypass (CBP) for left ventricular assist device (LVAD) implantation yields no significant survival benefit but leads to worse bleeding, according to a recent study.

Treatment with the RNAi therapeutic lumasiran led to a significant reduction in plasma oxalate and pre-dialysis oxalate levels in patients with advanced primary hyperoxaluria type 1 (PH1), according to the 6-month primary analysis of phase III ILLUMINATE-C trial presented at ASN Kidney Week 2021.

The oral HIF-PHI* daprodustat was noninferior to standard treatment with erythropoiesis-stimulating agents (ESAs) for increasing haemoglobin levels to within target range, without increasing cardiovascular (CV) risk in patients with anaemia due to chronic kidney disease (CKD), regardless of whether they were dialysis dependent or not, according to the phase III ASCEND-D/-ND trials presented at ASN 2021.